POM-V Prescription Required

Dilaterol 25 micrograms/ml Syrup for Horses

Active ingredient: Clenbuterol Hydrochloride

Form

Syrup

Species

Horses

Manufacturer

Le Vet Beheer B.V.

VMD MA No.

41821/5009

What it's used for

Treatment of respiratory disease in horses where it is considered that airway obstruction due to bronchospasm and/or accumulation of mucus is a contributin...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Clenbuterol Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Dilaterol 25 micrograms/ml Syrup for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Treatment of respiratory disease in horses where it is considered that airway
obstruction due to bronchospasm and/or accumulation of mucus is a contributing
factor, and improved mucociliary clearance is desirable. To be used alone or as
adjuvant therapy.

Do not use in cases of known hypersensitivity to the active substance or any of the
excipients.
Do not use in horses with known cardiac disease.
For use during pregnancy or lactation see section 4.7.

Revised: March 2024
AN: 03795/2022

Rare
(1 to 10 animals / 10,000
animals treated):
Restlessness;
Tachycardia, Hypotension
a
;
Muscle tremor;
Hyperhidrosis
b
a
slight
b
mainly neck region

Revised: March 2024
AN: 03795/2022
These adverse events are typical for -agonists.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

None.

Special precautions for use in animals
In cases accompanied by bacterial infection the administration of antimicrobial
agents is recommended.
In case of glaucoma the product must only be used after a careful risk-benefit
assessment.
Special precautions should be taken in case of halothane anaesthesia, since the
heart function can show increased sensitivity to catecholamines.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
This product contains clenbuterol hydrochloride, a beta-agonist.
Wear gloves to avoid skin contact. In case of accidental skin contact, wash
affected area thoroughly. If irritation occurs/persists seek medical advice. Wash
hands thoroughly after using the product.
Take care to avoid eye contact. In the case of accidental eye contact, flush
thoroughly with clean water and seek medical advice.
Do not eat, drink or smoke when using this product. In case of accidental ingestion,
seek medical advice immediately and show the package leaflet or the label to the
physician.
People with known hypersensitivity to clenbuterol should avoid contact with the
veterinary medicinal product.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.

The product antagonises the effects of prostaglandin F2 -alpha and oxytocin.
The product is antagonised by -adrenergic blocking agents.
Do not administer concurrently with other beta-adrenergic agents.
During the use of both local and general anaesthetics one cannot exclude a further
vascular dilatation and fall of blood pressure, particularly if used in combination
with atropine.

Do not store above 25°C. Protect from light.

Meat and offal:28 days
Not authorised for use in lactating animals producing milk for human consumption.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.